ALERE INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2016-12-08: Study NCT03194880; Company role Collaborator; Phase Observational; Status Completed.
- 2016-06: Study NCT04107220; Company role Collaborator; Phase Not applicable; Status Unknown.
- 2011-12: Study NCT01497054; Company role Collaborator; Phase Observational; Status Completed.
- 2010-12: Study NCT01291836; Company role Collaborator; Phase Observational; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2016-12-08 | NCT03194880 Alere COMBO and Alere q Detect in an HIV PrEP Program in Thailand | Collaborator Lead: Thai Red Cross AIDS Research Centre | Observational | Completed | HIV | 150 | 2023-02-10 |
| 2016-06 | NCT04107220 Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure | Collaborator Lead: Unity Health Toronto | Not applicable | Unknown | Heart Failure | 300 | 2020-06 |
| 2011-12 | NCT01497054 Do Elevated BNP Levels Predict Hemodynamically Significant PDAs | Collaborator Lead: Albany Medical College | Observational | Completed | Patent Ductus Arteriosus | 109 | 2013-04 |
| 2010-12 | NCT01291836 Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study | Collaborator Lead: Alere San Diego | Observational | Completed Results posted | Acute Decompensated Heart Failure; Acute Kidney Injury | 930 | 2015-06 |